Zentalis Pharmaceuticals, Inc. (ZNTL) Net Margin
- 2024-12-31: Net Margin -176.71%.
- 2024-03-31: Net Margin 24.82%.
Complete source-backed net margin history.
- Available history
- 2024-03-31 to 2024-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2024-12-31 | -176.71% |
| 2024-03-31 | 24.82% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2024-12-31 | -245.96% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |